NCPA and other national pharmacy organizations filed comments responding to a request for information from the Department of Health and Human Services on federal vaccine recommendations and shared clinical decision-making. Together, the coalition urged HHS to maintain a transparent, scientifically rigorous, and evidence-based vaccine recommendation process, while ensuring pharmacists are represented in vaccine policy discussions through the agency’s Advisory Committee on Immunization Practices.
The letter also emphasized preserving the current framework of routine, risk-based, and shared clinical decision-making recommendations to provide clarity for providers and patients and support consistent implementation. Finally, the organizations stressed that any changes to vaccine recommendation categories should protect patient access to affordable vaccines, preserve insurance coverage pathways, and avoid unintended disruptions to public health programs.
Read the comments here.
